Term Name: rolapitant hydrochloride (anhydrous)
Synonyms: (5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-oxo-8-phenyl-1,7-diazaspiro[4.5]decan-7-ium chloride, (5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride, rolapitant hydrochloride, Rolapitant hydrochloride anhydrous, rolapitant monohydrochloride, rolapitant.HCl, SCH 619734, SCH619734
Definition: A hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of the hydrate) for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
Ontology: ChEBI [CHEBI:90912]  ( EBI )

Relationships
is a type of: hydrochloride
has_part: rolapitant(1+)
has_role: antiemetic neurokinin-1 receptor antagonist
inverse has_part: rolapitant hydrochloride hydrate